clinical trial · NCT00403949
A Study of Azelaic Acid (AzA) 15% in Topical Treatment of Mild to Moderate Perioral Dermatitis
LEO Pharma·phase2·completed·n = 48
Perioral DermatitisAzelaic acid 15% gelNon-active base from azelaic acid 15% gel
brief summary
The purpose of this study is to test the efficacy and safety of AzA 15% Gel in the treatment of mild to moderate perioral dermatitis.
started
Nov 1, 2006
primary completion
Mar 1, 2007
completion
Mar 1, 2007
last updated
Jun 9, 2023
official title
A 6-week, Vehicle-controlled, Randomized, Double-blind, Parallel-group Multicenter Pilot Study of the Efficacy and Safety of Azelaic Acid (AzA) 15% Gel in the Topical Treatment of Mild to Moderate Perioral Dermatitis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol